Pila Pharma's CEO is Gustav Gram, appointed in Apr 2024, has a tenure of 2.25 years. directly owns 0.45% of the company’s shares, worth €24.06K. The average tenure of the management team and the board of directors is 2.3 years and 6.5 years respectively.
Key information
Gustav Gram
Chief executive officer
SEK 1.6m
Total compensation
CEO salary percentage
n/a
CEO tenure
2.3yrs
CEO ownership
0.5%
Management average tenure
2.3yrs
Board average tenure
6.5yrs
Recent management updates
Recent updates
CEO
Gustav Gram (33 yo)
2.3yrs
Tenure
SEK 1,562,369
Compensation
Mr. Gustav Hanghoj Gram is Chief Executive Officer of Pila Pharma AB (publ) from April 18, 2024. Mr. Gram was Head of Office of Pila Pharma AB (publ) until April 18, 2024.
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Dorte Gram
Founder
12.3yrs
SEK 1.61m
13.8% € 731.0k
Gustav Gram
Chief Executive Officer
2.3yrs
SEK 1.56m
0.45% € 24.1k
Hampus Darrell
Chief Financial Officer
1.6yrs
SEK 609.84k
no data
Miguel Lecumberri
Head of Compliance & Legal Affairs
no data
no data
no data
Masoud Alavi
Head of Corporate Visual Communication
no data
no data
no data
Andy Makin
Head of Toxicology
no data
no data
no data
Maura McArdle
Head of BD & Quay Pharma
no data
no data
no data
Mike Frodsham
CTO of Quay Pharma
no data
no data
no data
Alison Foster
Head of Pre-Clinical - Quay Pharma
no data
no data
no data
Simon Hamilton
Head of Global Business Development - Almac
no data
no data
no data
Claire McCambley
Head of Analytical Development - Almac
no data
no data
no data
2.3yrs
Average Tenure
53yo
Average Age
Experienced Management: 5KC's management team is considered experienced (2.3 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Dorte Gram
Founder
12.3yrs
SEK 1.61m
13.8% € 731.0k
Richard Busellato
Independent Director
3.2yrs
SEK 225.00k
0.18% € 9.3k
Bo Ahrén
Member of Scientific Advisory Board
6.5yrs
no data
no data
Arpad Szallasi
Member of Scientific Advisory Board
13.5yrs
no data
no data
Mark Evans
Member of Scientific Advisory Board
6.5yrs
no data
no data
Jens Holst
Member of Scientific Advisory Board
13.5yrs
no data
no data
Lasse Petersen
Independent Director
2.3yrs
SEK 225.00k
0.21% € 10.9k
Thomas Lutz
Member of Scientific Advisory Board
less than a year
no data
no data
6.5yrs
Average Tenure
59yo
Average Age
Experienced Board: 5KC's board of directors are considered experienced (6.5 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/16 17:25
End of Day Share Price
2026/07/16 00:00
Earnings
2025/12/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Pila Pharma AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.